Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

CRISPR activation and interference screens decode stimulation responses in primary human T cells
Ralf Schmidt, Zachary Steinhart, Madeline Layeghi, et al.
Science (2022) Vol. 375, Iss. 6580
Open Access | Times Cited: 182

Showing 1-25 of 182 citing articles:

Clinical implications of T cell exhaustion for cancer immunotherapy
Andrew Chow, Karlo Perica, Christopher A. Klebanoff, et al.
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 12, pp. 775-790
Open Access | Times Cited: 435
Phenotypic drug discovery: recent successes, lessons learned and new directions
Fabien Vincent, Arsenio Nueda, Jonathan Lee, et al.
Nature Reviews Drug Discovery (2022) Vol. 21, Iss. 12, pp. 899-914
Open Access | Times Cited: 176
Non-viral precision T cell receptor replacement for personalized cell therapy
Susan P. Foy, Kyle Jacoby, Daniela A. Bota, et al.
Nature (2022) Vol. 615, Iss. 7953, pp. 687-696
Open Access | Times Cited: 166
Epigenetic regulation of T cell exhaustion
Julia A. Belk, Bence Dániel, Ansuman T. Satpathy
Nature Immunology (2022) Vol. 23, Iss. 6, pp. 848-860
Open Access | Times Cited: 157
RASA2 ablation in T cells boosts antigen sensitivity and long-term function
Julia Carnevale, Eric Shifrut, Nupura Kale, et al.
Nature (2022) Vol. 609, Iss. 7925, pp. 174-182
Open Access | Times Cited: 117
Next-Generation CAR T-cell Therapies
Regina M. Young, Nils W. Engel, Uğur Uslu, et al.
Cancer Discovery (2022) Vol. 12, Iss. 7, pp. 1625-1633
Open Access | Times Cited: 112
Predicting transcriptional outcomes of novel multigene perturbations with GEARS
Yusuf Roohani, Kexin Huang, Jure Leskovec
Nature Biotechnology (2023) Vol. 42, Iss. 6, pp. 927-935
Open Access | Times Cited: 95
Progress and Prospect of Immunotherapy for Triple-Negative Breast Cancer
Chenyi Luo, Peipei Wang, Siqi He, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 87
Recent advances and applications of CRISPR-Cas9 in cancer immunotherapy
Zaoqu Liu, Meixin Shi, Yuqing Ren, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 75
Comparative analysis of cell–cell communication at single-cell resolution
Aaron J. Wilk, Alex K. Shalek, Susan Holmes, et al.
Nature Biotechnology (2023) Vol. 42, Iss. 3, pp. 470-483
Open Access | Times Cited: 53
CRISPR-Cas-mediated transcriptional modulation: The therapeutic promises of CRISPRa and CRISPRi
Louise Bendixen, Trine I. Jensen, Rasmus O. Bak
Molecular Therapy (2023) Vol. 31, Iss. 7, pp. 1920-1937
Open Access | Times Cited: 46
Multiplex, single-cell CRISPRa screening for cell type specific regulatory elements
Florence M. Chardon, Troy A. McDiarmid, Nicholas F. Page, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Maximizing CRISPRi efficacy and accessibility with dual-sgRNA libraries and optimal effectors
Joseph M. Replogle, Jessica L. Bonnar, Angela N. Pogson, et al.
eLife (2022) Vol. 11
Open Access | Times Cited: 59
Multiplex base- and prime-editing with drive-and-process CRISPR arrays
Qichen Yuan, Xue Gao
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 52
A T cell resilience model associated with response to immunotherapy in multiple tumor types
Yu Zhang, Trang Vu, Douglas C. Palmer, et al.
Nature Medicine (2022) Vol. 28, Iss. 7, pp. 1421-1431
Open Access | Times Cited: 41
CRISPR screens for functional interrogation of immunity
Hao Shi, John G. Doench, Hongbo Chi
Nature reviews. Immunology (2022) Vol. 23, Iss. 6, pp. 363-380
Closed Access | Times Cited: 41
Multidimensional single-cell analysis identifies a role for CD2-CD58 interactions in clinical antitumor T cell responses
Gabrielle Romain, Paolo Strati, Ali Rezvan, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 17
Open Access | Times Cited: 35
Base-editing mutagenesis maps alleles to tune human T cell functions
Ralf Schmidt, Carl C. Ward, Rama Dajani, et al.
Nature (2023) Vol. 625, Iss. 7996, pp. 805-812
Open Access | Times Cited: 29
Transcriptional and epigenetic regulators of human CD8+ T cell function identified through orthogonal CRISPR screens
Sean R. McCutcheon, Adam M. Swartz, Michael C. Brown, et al.
Nature Genetics (2023) Vol. 55, Iss. 12, pp. 2211-2223
Open Access | Times Cited: 26
Engineered Treg cells as putative therapeutics against inflammatory diseases and beyond
Sebastian Bittner, Thomas Hehlgans, Markus Feuerer
Trends in Immunology (2023) Vol. 44, Iss. 6, pp. 468-483
Open Access | Times Cited: 24
BCL2 Inhibition Reveals a Dendritic Cell–Specific Immune Checkpoint That Controls Tumor Immunosurveillance
Liwei Zhao, Peng Liu, Misha Mao, et al.
Cancer Discovery (2023) Vol. 13, Iss. 11, pp. 2448-2469
Open Access | Times Cited: 22
Modular pooled discovery of synthetic knockin sequences to program durable cell therapies
Franziska Blaeschke, Yan Yi Chen, Ryan Apathy, et al.
Cell (2023) Vol. 186, Iss. 19, pp. 4216-4234.e33
Open Access | Times Cited: 22
Cell softness renders cytotoxic T lymphocytes and T leukemic cells resistant to perforin-mediated killing
Yabo Zhou, Dianheng Wang, Li Zhou, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 7
Bidirectional epigenetic editing reveals hierarchies in gene regulation
Naomi M. Pacalin, Zachary Steinhart, Quanming Shi, et al.
Nature Biotechnology (2024)
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top